Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospec

  • PDF / 375,565 Bytes
  • 1 Pages / 595.276 x 790.866 pts Page_size
  • 107 Downloads / 217 Views

DOWNLOAD

REPORT


CORRECTION

Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi‑Institutional Analysis Roberto Iacovelli1 · Chiara Ciccarese1,2 · Gaetano Facchini3 · Michele Milella4 · Federica Urbano5 · Umberto Basso6 · Ugo De Giorgi7 · Roberto Sabbatini8 · Daniele Santini9 · Rossana Berardi10 · Matteo Santoni11 · Sergio Bracarda12 · Francesco Massari13 · Cristina Masini14 · Michele De Tursi15 · Riccardo Ricotta16 · Sebastiano Buti17 · Fable Zustovich18 · Pierangela Sepe19 · Sabrina Rossetti3 · Marco Maruzzo6 · Enrico Cortesi5 · Giampaolo Tortora1,2 · Giuseppe Procopio19

© Springer Nature Switzerland AG 2020

Correction to: Targeted Oncology https​://doi.org/10.1007/s1152​3-020-00732​-y

While typesetting the article the Table 3 column/row entries are interchanged. Please find below the updated Table 3.

The original article can be found online at https​://doi.org/10.1007/ s1152​3-020-00732​-y. * Roberto Iacovelli [email protected]

Table 3  Cross-response to nivolumab and cabozantinib Response to nivolumab

Response to cabozantinib CR/PR

SD

PD

CR/PR SD PD Total

9 14 15 38

1 7 11 19

2 6 9 17

9

Total

12 27 35 74



Oncologia Medica, Campus Bio-Medico University of Rome, Rome, Italy

10



Oncologia Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, 00158 Rome, Italy

Clinica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I, Ancona, Italy

2

11



Oncologia Medica, Facoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Rome, Italy

Oncologia Medica, Ospedale di Macerata, Via Santa Lucia 2, 62100 Macerata, Italy

3

12

Departmental Unit of Clinical and Experimental Uro‑Andrologic Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy

S.C. Medical Oncology, Azienda Ospedaliera S. Maria, Terni, Italy

13

Dipartimento di Oncologia Medica, Ospedale Sant’Orsola-Malpighi, Bologna, Italy

14

Medical Oncology Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

15

Dipartimento di Scienze Orali e Mediche, Sezione di Oncologia, Università G. D’Annunzio, Chieti, Italy

16

Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy

17

Unità Operativa di Oncologia Medica, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy

18

Oncologia Medica, San Martino Hospital, Belluno, Italy

19

Genitourinary Cancer Unit, Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

1



4

Oncologia Medica, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy

5

Oncology Unit, Department of Radiology, Oncology and Human Pathology, Sapienza University of Rome, Rome, Italy

6

Medical Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy

7

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

8

Department of Oncology, Hematology